Abstract
Increase in body size increases the risk of renal stone formation. The mechanism explaining this relationship remains unclear. Urine pH is one of the important factors for urinary stone formation. The purpose of this study was to determine whether there is an association between urine pH and body mass index (BMI) in patients with urolithiasis. Medical charts review that included 342 urinary stone formers (248 men and 94 women). Data obtained included patient sex, age, BMI, urine pH at diagnosis, and stone composition. The patients were classified as normal weight (18.5 ≤ BMI < 24), overweight (24 ≤ BMI < 27), or obese (BMI ≥ 27). The mean urine pH of the normal body weight, overweight, and obese groups was 6.25, 6.14, and 6.00, respectively (P < 0.05). Urine pH is inversely related to BMI among patients with urolithiasis. Among patients with urolithiasis, higher BMI will have lower urine pH. This may explain why obesity is associated with an increased risk of nephrolithiasis. Weight loss should be explored as a potential treatment to prevent kidney stone formation. The prevention of urinary stone disease gives clinicians an additional reason to encourage weight reduction through diet.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Urolithiasis is a major cause of morbidity. The lifetime prevalence rate of symptomatic urolithiasis is approximately 5–10% in the general population and there is male predominance [1, 2]. The etiology of urinary stone disease is multifactorial and not completely understood [3, 4]. The prevalence of urinary stone disease is increasing in the United States as well as in other countries [1, 5], in parallel with the escalating rate of obesity in many nations [6, 7]. The prevalence and incidence of stone disease have been reported to be associated with body weight and body mass index (BMI) [8–10]. In Taiwan, the prevalence of overweight and obesity in the general population was 25.8 and 16.8%, respectively [11]. Identification of common, modifiable risk factors for urinary stones may result in new approaches to treatment and prevention.
The correlation among urinary stone disease, body weight, and urinary pH is unclear. Based on the above observations, we sought to determine whether there is an association between BMI and urine pH in patients with urolithiasis.
Methods
We retrospectively reviewed data from patients with urolithiasis from December 2005 to January 2007. The data included patient sex, age, BMI, urine pH at diagnosis, and stone composition. Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters. BMI cutoffs were adopted as suggested by the Department of Health in Taiwan including normal (18.5 ≤ BMI < 24), overweight (24 ≤ BMI < 27) and obese (BMI ≥ 27) categories. The composition of stones was analyzed by using infrared spectrophotometry. Before stone removal, three spot urine samples were collected from the patients. Urine samples were analyzed by using an automated urine test strip analyzer, the Aution Max AX 4280 (Arkray Inc., Kyoto, Japan), which uses strips (Aution sticks-10EA, Arkray Inc., Kyoto, Japan) able to measure ten urinary parameters. The mean urine pH was calculated from the three spot urine samples.
Urine pH was compared among BMI and stone composition groups with one-way ANOVA. The differences in BMI, urinary pH and stone composition between men and women were analyzed by means of Pearson’s chi-square test or Student’s t test. Statistical significance was defined as two-tailed P less than 0.05. Statistical analysis was performed with SPSS version 12.0.
Results
Data from 342 patients, 248 men (72.5%) and 94 women (27.5%), were analyzed (Table 1). The mean age of the patients was 54.2 years and the mean BMI was 25.8 kg/m2. There were 85 (24.9%) patients who were normal weight, 135 (39.5%) who were overweight, and 122 (35.7%) who were obese. The stone composition was calcium oxalate (CaOx) in 110 (32.2%) patients, calcium phosphate (CaP) in 35 (10.2%), uric acid (UA) in 32 (9.4%), and combined calcium oxalate and calcium phosphate in 165 (48.2%). The differences in BMI, urinary pH and stone composition between men and women were listed in Table 2. Male stone formers had significantly higher BMI and lower urine pH than females. Female stone formers had higher proportion of CaOx and CaP stones and lower proportion of mixed and UA stones than males.
Urine pH displayed a stepwise decrease with increasing BMI (Fig. 1). The mean urine pH of the normal weight, overweight, and obese patients was 6.25, 6.14, and 6.00, respectively, which was a statistically significant difference among the groups (P = 0.021). Urine pH is inversely related to BMI among patients with urolithiasis. In addition, the mean urine pH of the CaP, mixed composition, CaOx, and UA stone groups was 6.46, 6.23, 6.01, and 5.5, respectively, which also was a statistically significant difference among the groups (P < 0.001). The proportion of obesity in the CaP, mixed composition, CaOx, and UA stone groups was 34.3, 38.7, 42.7, and 53.1%, respectively. The UA stone formers had significantly higher proportion of obesity than other stone formers (P = 0.012).
Discussion
Increase of body size increases the risk of renal stone formation. The mechanism that explains this relationship is still unclear. Urine pH is one of the important factors for urinary stone formation. The purpose of our study was to investigate whether there is an association between urine pH and BMI in patients with urolithiasis. We found that urine pH significantly decreases with increasing BMI. Studies of several groups of individuals with nephrolithiasis have also demonstrated that higher weight is associated with lower urine pH [12, 13].
The reasons for a progressive decline in urine pH with increasing BMI in patients with urolithiasis are uncertain. Hyperinsulinemia or insulin resistance is one of the possible reasons. Overweight or obese people have a higher incidence of diabetes mellitus which is correlated with hyperinsulinemia or insulin resistance. Insulin is known to stimulate the synthesis of ammonia and sodium–hydrogen exchange in the renal tubule which mediates ammonium excretion in urine [14, 15]. Insulin resistance may manifest in the kidney as a defect in ammonium production and the ability to excrete acid, and thus affect urine pH [16]. Recent data have confirmed that insulin resistance in humans is associated with lower urine pH [17]. Hyperinsulinemia could also lead to decreased urinary citrate and increased urinary excretion of calcium, uric acid, and oxalate, which are important risk factors for calcium nephrolithiasis [17].
Another possible reason is gouty diathesis and increasing urinary uric acid excretion. Overweight or obesity are associated with an increased risk of gouty diathesis which often results in increased urine uric acid excretion, an acidific urine environment, and uric acid stone formation. Epidemiologic studies have also shown that type 2 diabetes is significantly associated with an increased risk of uric acid stone formation in comparison to stone formation without diabetes [18, 19]. Men who weighed more than 120 kg had a urinary concentration of uric acid 13% greater than men who weighed less than 100 kg [13]. Moreover, the prevalence of gout was 30% in overweight and obese men compared with 18% in normal weight men. Similar findings were observed in women [9]. Increased urinary uric acid excretion not only affects uric acid stone formation but also is a risk factor for calcium oxalate stone formation, since calcium oxalate stones may also develop by heterogeneous nucleation of calcium oxalate by uric acid [20, 21].
In conclusion, our study showed that urine pH is inversely related to body mass index among patients with urolithiasis. Therefore, patients with higher BMI will have lower urine pH. This may explain why obesity is associated with an increased risk of nephrolithiasis. Weight loss should be explored as a potential treatment to prevent kidney stone formation. The prevention of urinary stone disease gives clinicians an additional reason to encourage weight reduction through diet.
References
Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823
Johnson CM, Wilson DM, O’Fallon WM et al (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16:624–631
Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152
Levy FL, Adams-Huet B, Pak CY (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98:50–59
Yoshida O, Terai A, Ohkawa T et al (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904
Flegal KM, Carroll MD, Ogden CL et al (2002) Prevalence and trends in obesity among US adults 1999–2000. JAMA 288:1723–1727
Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643
Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462
Siener R, Glatz S, Nicolay C et al (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106–113
Curhan GC, Willett WC, Rimm EB et al (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652
Hwang LC, Bai CH, Chen CJ (2006) Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006(105):626–635
Maalouf NM, Sakhaee K, Parks JH et al (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65:1422–1425
Powell CR, Stoller ML, Schwartz BF et al (2000) Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55:825–830
Chobanian MC, Hammerman MR (1987) Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 253:F1171–F1177
Klisec J, Hu MC, Nief V et al (2002) Insulin activates the Na+/H+ exchanger 3: biphasic response and glucocorticoid-dependence. Am J Physiol Renal Physiol. 283:F532–F539
Kamel KS, Cheema-Dhadli S, Halperin ML (2002) Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int 61:988–994
Abate N, Chandalia M, Cabo-Chan AV Jr et al (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392
Daudon M, Traxer O, Conort P et al (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033
Pak CY, Sakhaee K, Moe O et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523–527
Grases F, Sanchis P, Perello J et al (2006) Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol 13:252–256
Coe FL (1978) Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 13:418–426
Acknowledgments
The study was supported by grants from The Bureau of Health, The Kaohsiung City Government. The authors thank Miss Hsing-Hsu for assistance of manuscript preparation. The study was approved by the Institutional Review Board of the Kaohsiung Medical University Hospital.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, WM., Chou, YH., Li, CC. et al. Association of body mass index and urine pH in patients with urolithiasis. Urol Res 37, 193–196 (2009). https://doi.org/10.1007/s00240-009-0194-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-009-0194-4